Login / Signup

Dendritic cell vaccine as a potential strategy to end the COVID-19 pandemic. Why should it be Ex Vivo ?

Jonny JonnyTerawan Agus PutrantoEnda Cindylosa SitepuRaoulian Irfon
Published in: Expert review of vaccines (2022)
loaded DC-based vaccination is appropriate for COVID-19 prevention.
Keyphrases
  • dendritic cells
  • coronavirus disease
  • sars cov
  • regulatory t cells
  • drug delivery
  • immune response
  • cancer therapy
  • human health
  • wound healing
  • respiratory syndrome coronavirus
  • climate change